Nat Rev Nephrol. 2011 Mar;7(3):128-30. doi: 10.1038/nrneph.2010.168. Epub 2010 Dec 21.
The optimal blood-pressure goals to prevent progression of chronic kidney disease (CKD) remain controversial. The results of the AASK cohort study provide additional support for more aggressive blood-pressure control (<130/90 mmHg) in proteinuric but not nonproteinuric patients with hypertensive CKD.
预防慢性肾脏病(CKD)进展的最佳血压目标仍存在争议。AASK 队列研究的结果为蛋白尿但非非蛋白尿高血压 CKD 患者提供了更多支持,即更积极的血压控制(<130/90mmHg)。